Joint pain with aromatase inhibitors: Abnormal frequency of Sjögren's syndrome

Journal of Rheumatology

Volumn 34, Issue 11, 2007, Pages 2259-2263

  Laroche, Michel ^a   Borg, Séverine ^a   Lassoued, Slim ^a   De Lafontan, Brigitte ^b   Roché, Henri ^b  

^a CHU RANGUEIL   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Aromatase inhibitors; Estrogen; Joint pain; Sj gren's syndrome; Women

Indexed keywords

ANASTROZOLE; ANTINUCLEAR ANTIBODY; AROMATASE INHIBITOR; CORTICOSTEROID; ESTROGEN; EXEMESTANE; PLACEBO; RHEUMATOID FACTOR; TAMOXIFEN; TRASTUZUMAB; TRIPTORELIN;

ADULT; AGED; ANTIBODY TITER; ARTHRALGIA; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CLINICAL ARTICLE; DRUG WITHDRAWAL; ESTROGEN METABOLISM; FEMALE; FRACTURE; HASHIMOTO DISEASE; HEPATITIS C; HUMAN; LOW DRUG DOSE; OSTEOARTHRITIS; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SJOEGREN SYNDROME; TENDINITIS; UTERUS DISEASE; VASCULAR DISEASE;

AGED; ANTIBODIES, ANTINUCLEAR; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; ARTHRALGIA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; MIDDLE AGED; NITRILES; SJOGREN'S SYNDROME; TAMOXIFEN; TRIAZOLES;

EID: 35948957848     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Howell A, Cuzick J, Baum M, et al; ATAC Trialists' Group. Result of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005;365:60-2.
2. Laroche M, Arlet P, Authier JP, Cantagrel A, Mazières B, Arlet J. The compress test, an easy test for diagnosing and evaluating xerostomy [French]. Presse Med 1987;16:1704.
3. Fox RI, Howell FV, Bone RC, Michelson P. Primary Sjogren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum 1984;14:77-105.
4. Felson DT, Cummings SR. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 2005;52:2594-8.
5. Donnellan PP, Douglas SL, Cameron DA, Leonard RC. Aromatase inhibitors and arthralgia. J Clin Oncol 2001;19:2767.
6. Ohsako T, Inoue K, Nagamoto N, Yoshida Y, Nakahara O, Sakamoto N. Joint symptoms: a practical problem of anastrozole. Breast Cancer 2006;13:284-8.
7. Morales L, Pans S, Paridaens R, et al. Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Res Treat 2007;104:87-91. Epub 2006 Oct 24.
8. Boccardo F, Rubagotti A, Puntoni M, et al. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial. J Clin Oncol 2005;23:5138-47.
9. Lonning PE. Pharmacology of aromatase inhibitors. Breast 1996;5:206-8.
10. Cecil RL, Archer BH. Arthritis of the menopause. JAMA 1925;84:75-9.
11. Greendale GA, Reboussin BA, Hogan P, et al. Symptom relief and side effects of postmenopausal hormones: results from the Post-menopausal Estrogen/Progestin Replacement Interventions Trial. Obstet Gynecol 1998;92:982-8.
12. Nevitt MC, Felson DT, Williams EN, Grady D. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women. Arthritis Rheum 2001;44:811-8.
13. Kurebayashi S, Miyashita Y, Hirose T, Kasayama S, Akira S, Kishimoto T. Characterization of mechanisms of interleukin-6-gene repression by estrogen receptor. J Steroid Biochem Mol Biol 1997;60:11-7.
14. Vural P, Akgul C, Canbaz M. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Pharmacol Res 2006;54:298-302.
15. Friedman AJ, Juneau-Norcross M, Rein MS. Adverse effects of leuprolide acetate depot treatment. Fertil Steril 1993;59:448-50.
16. Blomqvist A. Sex hormones and pain: a new role for brain aromatase? J Comp Neurol 2000;423:549-51.
17. Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997;40:1601-11.
18. Nilsson BO, Skogh T, Ernerudh J, et al. Antinuclear antibodies in the oldest-old women and men. J Autoimmun 2006;27:281-8.
19. Shearn MA. Sjogren's syndrome. Semin Arthritis Rheum 1972;2:165-91.
20. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-3.
21. Cutolo M, Sulli A, Capellino S, et al. Sex hormones' influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004;13:635-8.
22. Foster H, Stephenson A, Walker D, et al. Linkage study of HLA and primary Sjogren's syndrome in multicase families. Arthritis Rheum 1993;36:473-84.
23. Moutsopoulos HM, Manoussakis MN. Immunopathogenesis of Sjogren's syndrome: "facts and fancy". Autoimmunity 1989;5:17-24.
24. Brennan MT, Sankar V, Leakan RA, Grisius MM, et al. Sex steroid hormones in primary Sjogren's syndrome. J Rheumatol 2003;30:1267-71.
25. Taiym S, Haghighat N, Al-Hashimi I. A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:579-83.
26. Shim GJ, Warner M, Kim HJ, et al. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc Natl Acad Sci USA 2004;101:12628-33.
27. Hayashi Y, Arakaki R, Ishimaru N. Apoptosis and estrogen deficiency in primary Sjogren syndrome. Curr Opin Rheumatol 2004;16:522-6.
28. Haneji N, Nakamura T, Takio K, et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 1997;276:604-7.